CSF2RA and rheumatoid arthritis: This review synthesizes current mechanistic insights and clinical evidence regarding GM-CSF and GM-CSFR inhibition in RA, with the aim of critically assessing the therapeutic potential of targeting this pathway as an innovative strategy for durable immune modulation and improved disease control.